Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK).
Fraser SA
,
Gimenez I
,
Cook N
,
Jennings I
,
Katerelos M
,
Katsis F
,
Levidiotis V
,
Kemp BE
,
Power DA
.
???displayArticle.abstract???
The renal-specific NKCC2 (Na+-K+-2Cl- co-transporter 2) is regulated by changes in phosphorylation state, however, the phosphorylation sites and kinases responsible have not been fully elucidated. In the present study, we demonstrate that the metabolic sensing kinase AMPK (AMP-activated protein kinase) phosphorylates NKCC2 on Ser126 in vitro. Co-precipitation experiments indicated that there is a physical association between AMPK and the N-terminal cytoplasmic domain of NKCC2. Activation of AMPK in the MMDD1 (mouse macula densa-derived 1) cell line resulted in an increase in Ser126 phosphorylation in situ, suggesting that AMPK may phosphorylate NKCC2 in vivo. The functional significance of Ser126 phosphorylation was examined by mutating the serine residue to an alanine residue resulting in a marked reduction in co-transporter activity when exogenously expressed in Xenopus laevis oocytes under isotonic conditions. Under hypertonic conditions no significant change of activity was observed. Therefore the present study identifies a novel phosphorylation site that maintains NKCC2-mediated transport under isotonic or basal conditions. Moreover, the metabolic-sensing kinase, AMPK, is able to phosphorylate this site, potentially linking the cellular energy state with changes in co-transporter activity.
Bandyopadhyay,
Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
2006, Pubmed
Bandyopadhyay,
Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
2006,
Pubmed
Carattino,
Epithelial sodium channel inhibition by AMP-activated protein kinase in oocytes and polarized renal epithelial cells.
2005,
Pubmed
,
Xenbase
Darman,
A regulatory locus of phosphorylation in the N terminus of the Na-K-Cl cotransporter, NKCC1.
2002,
Pubmed
Davies,
5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC.
1995,
Pubmed
Dowd,
PASK (proline-alanine-rich STE20-related kinase), a regulatory kinase of the Na-K-Cl cotransporter (NKCC1).
2003,
Pubmed
Dyck,
Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits.
1996,
Pubmed
Ecelbarger,
Localization and regulation of the rat renal Na(+)-K(+)-2Cl- cotransporter, BSC-1.
1996,
Pubmed
Fraser,
Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality.
2005,
Pubmed
Fryer,
The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.
2002,
Pubmed
Gagnon,
Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter.
2006,
Pubmed
,
Xenbase
Giménez,
Spatially distributed alternative splice variants of the renal Na-K-Cl cotransporter exhibit dramatically different affinities for the transported ions.
2002,
Pubmed
,
Xenbase
Giménez,
Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein.
2003,
Pubmed
Giménez,
Regulatory phosphorylation sites in the NH2 terminus of the renal Na-K-Cl cotransporter (NKCC2).
2005,
Pubmed
,
Xenbase
Hallows,
Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase.
2000,
Pubmed
,
Xenbase
Kahle,
WNK3 modulates transport of Cl- in and out of cells: implications for control of cell volume and neuronal excitability.
2005,
Pubmed
,
Xenbase
Kemp,
AMP-activated protein kinase, super metabolic regulator.
2003,
Pubmed
Light,
Constitutively active adenosine monophosphate-activated protein kinase regulates voltage-gated sodium channels in ventricular myocytes.
2003,
Pubmed
Lytle,
The Na-K-Cl cotransport protein of shark rectal gland. II. Regulation by direct phosphorylation.
1992,
Pubmed
Michell,
Isoform-specific purification and substrate specificity of the 5'-AMP-activated protein kinase.
1996,
Pubmed
Moriguchi,
WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
2005,
Pubmed
Piechotta,
Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).
2002,
Pubmed
Riazi,
Rosiglitazone regulates ENaC and Na-K-2Cl cotransporter (NKCC2) abundance in the obese Zucker rat.
2006,
Pubmed
Song,
Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats.
2004,
Pubmed
Stapleton,
Mammalian AMP-activated protein kinase subfamily.
1996,
Pubmed
Starremans,
Mutations in the human Na-K-2Cl cotransporter (NKCC2) identified in Bartter syndrome type I consistently result in nonfunctional transporters.
2003,
Pubmed
,
Xenbase
Takahashi,
Uncompensated polyuria in a mouse model of Bartter's syndrome.
2000,
Pubmed
Wang,
5-amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways.
2005,
Pubmed
Woollhead,
Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells.
2005,
Pubmed
Yang,
Localization of bumetanide- and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron.
1996,
Pubmed
Ye,
Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats.
2006,
Pubmed
